Australia markets open in 9 hours 48 minutes

Lantern Pharma Inc. (LTRN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.24-0.04 (-0.62%)
As of 10:10AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
13,592
11,894
8,603
7,571
2,243
-
Selling general and administrative
5,731
5,983
5,830
5,021
3,665
-
Total operating expenses
19,323
17,878
14,433
12,592
5,908
-
Operating income or loss
-19,323
-17,878
-14,433
-12,592
-5,908
-
Total other income/expenses net
956.168
1,151
-31.548
160.55
-
-
Income before tax
-17,535
-15,962
-14,260
-12,363
-5,908
-
Income from continuing operations
-17,535
-15,962
-14,260
-12,363
-5,908
-
Net income
-17,535
-15,962
-14,260
-12,363
-5,908
-
Net income available to common shareholders
-17,535
-15,962
-14,260
-12,363
-5,908
-
Basic EPS
-1.39
-
-1.31
-1.13
-1.37
-0.39
Diluted EPS
-1.39
-
-1.31
-1.13
-1.37
-0.39
Basic average shares
10,857
-
10,851
10,905
4,305
6,218
Diluted average shares
10,857
-
10,851
10,905
4,305
6,218